Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

2 Absurdly Cheap Stocks to Buy and Hold for Years
2 Absurdly Cheap Stocks to Buy and Hold for Years

Buying stock in great companies when they are dealing with some short-term issue that creates stock price weakness can set investors up for big gains down the road. As long as the business is still

AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2024
2 Beaten-Down Stocks to Buy and Hold for a Decade
2 Beaten-Down Stocks to Buy and Hold for a Decade

Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key is to purchase shares of robust companies, occasionally adding more, and

EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement  of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
Good News for AMD Stock Investors
Good News for AMD Stock Investors

In this video, I will talk about recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?
Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply

Is AT&T Stock a Buy?
Is AT&T Stock a Buy?

AT&T (NYSE: T) is often considered a slow-growth stock -- the kind of investment people hold for stable returns and dividends rather than market-beating gains. But over the past 12 months, the

Why Major Pharmaceutical Stocks Tumbled on Tuesday
Why Major Pharmaceutical Stocks Tumbled on Tuesday

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump administration's promised tariffs were set to go into effect the following

Why Shares of Axsome Therapeutics Slumped Today
Why Shares of Axsome Therapeutics Slumped Today

Shares of biopharmaceutical company Axsome Therapeutics (NASDAQ: AXSM) had declined 6% at 11 a.m. ET today. The slump comes after the company announced the results of a phase 3 trial of solriamfetol

Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems
Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems


As of today, the Government of Saskatchewan’s expanded public coverage for continuous glucose monitoring (CGM) systems comes into effect. Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time

AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model.
AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model.
AEVIS VICTORIA SA - The hotel branch of AEVIS VICTORIA recorded strong growth in 2024, driven by the quality of its assets and the strength of its integrated model.
EQS-News: Newron presents 2024 financial results and provides 2025 outlook
EQS-News: Newron presents 2024 financial results and provides 2025 outlook
EQS-News: Newron presents 2024 financial results and provides 2025 outlook
Why Medtronic Stock Marched Higher on Monday
Why Medtronic Stock Marched Higher on Monday

Medtronic (NYSE: MDT) stock was a fairly hot item as the trading week kicked off, with investors pushing the shares up by almost 3% in value. They liked the medical device specialist's latest piece

Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today

Shares of biotechnology stocks such as Recursion Pharmaceuticals (NASDAQ: RXRX), Summit Therapeutics (NASDAQ: SMMT), and CRISPR Therapeutics AG (NASDAQ: CRSP) plunged on Monday, down 9.4%, 5.6%, and

Where Will AT&T Stock Be in 1 Year?
Where Will AT&T Stock Be in 1 Year?

AT&T (NYSE: T) shareholders have plenty to celebrate, with the stock up 24% thus far in 2025. The telecommunications giant has presented robust earnings, reinforcing an optimistic long-term outlook

VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships
VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships
VALBIOTIS SA: Valbiotis® strengthens its foothold in pharmacies with two strategic partnerships
EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius
EQS-News: First ISCC Plus certifications pave the way for renewable plastics at Sartorius
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

Building a retirement portfolio of $1 million or more is within reach for many Americans. The primary things you'll need are time and money to invest.

Do you want $1 million in retirement? There's

EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-Adhoc: Biotest AG: Delisting agreement and announced delisting tender offer
EQS-News: Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend
EQS-News: Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend
EQS-News: Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend
EQS-News: Biotest AG increases sales by 6% in financial year 2024
EQS-News: Biotest AG increases sales by 6% in financial year 2024
EQS-News: Biotest AG increases sales by 6% in financial year 2024
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends
Here's How Many Shares of AT&T You Should Own to Get $1,000 in Yearly Dividends

Dividend-paying stocks are hard to beat for income. If you're retired, you can use that money for your living expenses, and if you're still far from retirement, you might simply reinvest those

RTX May Bag a $4.2 Billion Big-Blimp Bonanza
RTX May Bag a $4.2 Billion Big-Blimp Bonanza

Forget stealth fighter jets, drones, and orbital, Earth-observing spy satellites. If you ask the U.S. Army, the future of Command, Control, Communications, Computers, Intelligence, Surveillance, and

3 Relatively Safe Stocks to Buy Right Now
3 Relatively Safe Stocks to Buy Right Now

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions.

Three Motley Fool contributors think